Selecta Biosciences (NASDAQ:SELB) Now Covered by assumed coverage on shares of Selecta Biosciences (NASDAQ:SELB – Free Report) in a research report report published on Wednesday morning. The firm issued a hold rating on the stock. Several other brokerages also recently weighed in on SELB. Leerink Partnrs downgraded Selecta Biosciences from an outperform rating to a market perform rating in a […]

Leave a Reply

Your email address will not be published.

Previous post Analog Devices (NASDAQ:ADI) PT Lowered to $206.00
Next post How can Chicago Bears and QB Justin Fields handle the Minnesota Vikings pressure better in Monday’s rematch?